Your browser doesn't support javascript.
loading
Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM study.
Schifferli, Alexandra; Rüfer, Axel; Rovo, Alicia; Nimmerjahn, Falk; Cantoni, Nathan; Holbro, Andreas; Favre, Geneviève; Dirks, Jan; Wieland, Anna; Faeth, Heike; Pereira, Renata; Kühne, Thomas.
Afiliação
  • Schifferli A; Department of Hematology/Oncology, University Children's Hospital Basel, Basel, Switzerland.
  • Rüfer A; Department of Hematology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Rovo A; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Nimmerjahn F; Department of Biology, Institute of Genetics, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Cantoni N; Department of Hematology, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Holbro A; Department of Hematology, University Hospital Basel, Basel, Switzerland.
  • Favre G; Department of Hematology, Cantonal Hospital Liestal, Switzerland.
  • Dirks J; Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
  • Wieland A; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Faeth H; Medical University of Basel, Basel, Switzerland.
  • Pereira R; Medical University of Basel, Basel, Switzerland.
  • Kühne T; Department of Hematology/Oncology, University Children's Hospital Basel, Basel, Switzerland.
Br J Haematol ; 203(1): 119-130, 2023 10.
Article em En | MEDLINE | ID: mdl-37735543

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article